Bellicum Pharmaceuticals Wins Big With FDA Decision
Bellicum Pharmaceuticals saw its shares rise early on Thursday after the firm announced a critical decision from the FDA.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 139
Pfizer’s Kidney Drug Not Up to Par
Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.
Are Analogic Shareholders Getting Enough in the Buyout?
Usually, when companies are being acquired they receive a premium on their share price. This does not seem to be the case for Analogic. Is this fair for shareholders?
Short Sellers Back Way Off Major Biotechs
The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The Major Pharma Stocks That Are Making Short Sellers Sick
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Selecta Biosciences Sinks Despite Positive Midstage Data
Selecta Biosciences saw its shares sink on Tuesday after the company presented new data from patients receiving SEL-212 for the treatment of chronic severe gout.
Why Spectrum Pharmaceuticals Is Climbing
Spectrum Pharmaceuticals saw its shares make a handy gain early on Tuesday after the firm provided an update on its midstage non-small cell lung cancer study.
Why Analysts See Pacira Pharma in a Night and Day Contrast
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid treatment…
Surface Oncology Announces Potential Pricing for IPO
Surface Oncology intends to price 6 million shares to result in an initial public offering valued up to more than $103 million.
Therapix Takes a Big Step Forward With Its Cannabinoid Platform
Therapix Biosciences shares made a solid gain to start the week after it announced topline results for its cannabinoid product platform.
Merck Moves Ahead With Late-Stage Trial Win
Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.
Why Menlo Therapeutics Shares Were Halved
Menlo Therapeutics shares were slaughtered early on Monday after the firm issued an update for its midstage clinical trial for patients with atopic dermatitis.
Novartis Gambles $8.7 Billion on Gene-Therapy Firm
Swiss drug maker Novartis has agreed to acquire U.S.-based AveXis for $8.7 billion in cash. AveXis is developing a gene-therapy to treat an inherited disease to treat the leading cause of gene-related infant death.
These 5 Stocks Could Be in Big Trouble If Interest Rates Go Higher
If interest rates continue higher, these five health care companies with floating rate debt could face some major issues.
What Has Tanked Incyte and NewLink Genetics
Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.